MeSH term
Frequency | Condition_Probility | Aged | 2 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Female | 9 | 0.0 |
Humans | 89 | 0.0 |
Male | 9 | 0.0 |
Middle Aged | 5 | 0.0 |
Animals | 36 | 0.0 |
Mice | 22 | 0.0 |
Microspheres | 2 | 1.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 34 | 0.0 |
Research Support, Non-U.S. Gov't | 70 | 0.0 |
Amino Acid Sequence | 14 | 0.0 |
Calcium/blood | 4 | 1.0 |
Ligands | 8 | 0.0 |
Lymphocytes/immunology | 2 | 0.0 |
Molecular Sequence Data | 15 | 0.0 |
Phylogeny | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 9 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Chemokines, CC/*pharmacology | 2 | 9.0 |
Chemotactic Factors/pharmacology | 4 | 12.0 |
In Vitro | 7 | 0.0 |
Kinetics | 2 | 0.0 |
Asthma/immunology | 2 | 5.0 |
Chemokines/*physiology | 2 | 6.0 |
Hypersensitivity/*immunology | 2 | 4.0 |
Th2 Cells/immunology | 5 | 3.0 |
Chromosomes, Human, Pair 3/*genetics | 2 | 0.0 |
Mice, SCID | 3 | 0.0 |
Tumor Cells, Cultured | 7 | 0.0 |
Chemotaxis, Leukocyte/*immunology | 2 | 4.0 |
Immunologic Memory | 4 | 1.0 |
Lymphocyte Activation | 7 | 0.0 |
Receptors, Chemokine/*metabolism | 10 | 7.0 |
Receptors, Cytokine/metabolism | 4 | 4.0 |
Chemokines, CC/metabolism | 4 | 9.0 |
Dexamethasone/pharmacology | 2 | 0.0 |
Receptors, Chemokine/genetics/metabolism | 2 | 8.0 |
Chemokines/*metabolism | 3 | 5.0 |
Receptors, Chemokine/metabolism | 4 | 3.0 |
Comparative Study | 11 | 0.0 |
HIV Infections/transmission/*virology | 2 | 18.0 |
Monocyte Chemoattractant Protein-1/metabolism | 2 | 3.0 |
Receptors, CCR5/metabolism | 5 | 3.0 |
Receptors, CXCR4/metabolism | 5 | 3.0 |
Receptors, HIV/chemistry/*metabolism | 2 | 50.0 |
Virus Replication | 6 | 0.0 |
Brain/*virology | 2 | 16.0 |
HIV-1/*physiology | 3 | 0.0 |
Leukocytes, Mononuclear/virology | 2 | 1.0 |
Macrophages/*virology | 3 | 5.0 |
Polymerase Chain Reaction | 6 | 0.0 |
Receptors, CXCR4/physiology | 3 | 6.0 |
Receptors, HIV/*physiology | 3 | 8.0 |
Biological Markers | 2 | 0.0 |
Cells, Cultured | 12 | 0.0 |
*Immunoconjugates | 2 | 0.0 |
Receptors, Chemokine/*biosynthesis | 3 | 7.0 |
*Receptors, Interleukin-2 | 2 | 50.0 |
Antigens, CD/metabolism | 2 | 0.0 |
Calcium/metabolism | 10 | 0.0 |
Chemokines, CXC/pharmacology | 4 | 5.0 |
Chemotaxis/physiology | 3 | 9.0 |
Flow Cytometry | 8 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 2 | 0.0 |
Phenotype | 2 | 0.0 |
Phosphorylation | 3 | 0.0 |
Receptors, Chemokine/genetics/*metabolism | 6 | 12.0 |
RNA, Messenger/analysis | 3 | 0.0 |
Chemokines, CXC/metabolism | 2 | 2.0 |
Calcium Signaling/drug effects | 2 | 4.0 |
Cell Line | 20 | 0.0 |
Chemokines | 2 | 50.0 |
Species Specificity | 2 | 0.0 |
Transfection | 13 | 0.0 |
Calcium Signaling/immunology | 2 | 9.0 |
RNA, Messenger/biosynthesis | 3 | 0.0 |
Receptors, CCR5/*metabolism | 2 | 1.0 |
Biopsy | 2 | 0.0 |
Chemokines, CC/*metabolism | 2 | 3.0 |
Immunohistochemistry | 8 | 0.0 |
Th2 Cells/*immunology/metabolism | 2 | 7.0 |
Hela Cells | 2 | 0.0 |
Chemotaxis, Leukocyte | 2 | 1.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Ovalbumin/administration & dosage/immunology | 2 | 12.0 |
RNA, Messenger/metabolism | 6 | 0.0 |
Th2 Cells/*immunology | 4 | 3.0 |
Receptors, Cell Surface/metabolism | 2 | 0.0 |
Up-Regulation/immunology | 2 | 1.0 |
Th1 Cells/*immunology | 3 | 2.0 |
Calcium Signaling | 2 | 2.0 |
Chemokines/pharmacology | 4 | 12.0 |
Pregnancy | 2 | 0.0 |
Chemotaxis, Leukocyte/immunology | 3 | 5.0 |
RNA, Messenger/analysis/biosynthesis | 2 | 0.0 |
Receptors, Chemokine/*biosynthesis/genetics/metabolism | 2 | 66.0 |
Chemotaxis/drug effects | 4 | 4.0 |
Cytokines/pharmacology | 3 | 0.0 |
Interleukin-2/pharmacology | 3 | 0.0 |
Radioligand Assay | 2 | 0.0 |
Clone Cells | 2 | 0.0 |
Th1 Cells/immunology/metabolism | 2 | 5.0 |
Th2 Cells/immunology/metabolism | 4 | 10.0 |
Receptors, Chemokine/*immunology | 3 | 10.0 |
Antibodies/pharmacology | 2 | 0.0 |
Chemokines, CC/metabolism/pharmacology | 2 | 12.0 |
Culture Media, Conditioned/pharmacology | 2 | 1.0 |
Umbilical Veins/cytology | 2 | 0.0 |
*Viral Proteins | 4 | 2.0 |
Adult | 8 | 0.0 |
Receptors, Chemokine/*analysis | 2 | 5.0 |
CD4-Positive T-Lymphocytes/virology | 2 | 2.0 |
Receptors, CXCR4/genetics/physiology | 2 | 33.0 |
Receptors, Chemokine/physiology | 4 | 15.0 |
*Receptors, G-Protein-Coupled | 4 | 1.0 |
*Saccharomyces cerevisiae Proteins | 2 | 0.0 |
Chemokines/*pharmacology | 2 | 7.0 |
Receptors, Chemokine/*physiology | 4 | 9.0 |
Time Factors | 3 | 0.0 |
Receptors, Chemokine/immunology | 2 | 6.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Binding, Competitive | 2 | 0.0 |
Protein Binding | 2 | 0.0 |
Signal Transduction | 2 | 0.0 |
Child, Preschool | 3 | 0.0 |
HIV Infections/*virology | 2 | 2.0 |
HIV-1/*metabolism/pathogenicity | 2 | 10.0 |
Infant | 3 | 0.0 |
RNA, Messenger/genetics/metabolism | 3 | 0.0 |
Receptors, HIV/*metabolism | 4 | 6.0 |
Chemokines, CC/physiology | 2 | 15.0 |
Neovascularization, Physiologic/*drug effects | 2 | 2.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
*Membrane Proteins | 2 | 0.0 |
Receptors, Chemokine/*genetics | 3 | 3.0 |
Receptors, Cytokine/genetics | 2 | 6.0 |
Chemokines/*immunology | 2 | 10.0 |
Receptors, Lymphocyte Homing/*immunology | 2 | 10.0 |
CHO Cells | 2 | 0.0 |
COS Cells | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Viral Proteins/*pharmacology | 2 | 11.0 |
Gene Expression Regulation/immunology | 2 | 1.0 |
Recombinant Proteins/pharmacology | 2 | 0.0 |
T-Lymphocyte Subsets/drug effects/*immunology | 2 | 7.0 |
Receptors, CXCR4/*physiology | 2 | 4.0 |
Chemokines/*biosynthesis | 2 | 6.0 |
*Chemokines, CC | 7 | 9.0 |
Chemotaxis | 3 | 1.0 |
Glomerular Mesangium/*metabolism | 2 | 20.0 |
Interferon Type II/pharmacology | 2 | 0.0 |
Interleukin-1/pharmacology | 2 | 0.0 |
RANTES/pharmacology | 3 | 5.0 |
Tumor Necrosis Factor-alpha/pharmacology | 2 | 0.0 |
Structure-Activity Relationship | 2 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
Genes, env | 2 | 3.0 |
Receptors, Peptide/metabolism | 2 | 6.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Base Sequence | 3 | 0.0 |
DNA Primers/genetics | 2 | 0.0 |
Gene Expression | 3 | 0.0 |
Infant, Newborn | 2 | 0.0 |
Receptors, CCR5/genetics | 3 | 4.0 |
Receptors, CXCR4/*metabolism | 2 | 1.0 |
Receptors, CCR5/*physiology | 2 | 4.0 |
Th1 Cells/immunology/*metabolism | 2 | 25.0 |
Th2 Cells/immunology/*metabolism | 3 | 25.0 |
Receptors, CCR5/genetics/*physiology | 2 | 28.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Chemotaxis, Leukocyte/drug effects | 2 | 2.0 |
Immunophenotyping | 3 | 0.0 |
Skin/*immunology | 2 | 1.0 |
Membrane Fusion | 2 | 1.0 |
*Receptors, Chemokine | 2 | 2.0 |
Protein Processing, Post-Translational | 2 | 0.0 |
*Evolution, Molecular | 2 | 0.0 |
Chemokines, CC/pharmacology | 4 | 12.0 |
Pertussis Toxin/pharmacology | 2 | 3.0 |
Cytokines/biosynthesis | 2 | 0.0 |
Cell Movement/*immunology | 2 | 2.0 |
Skin/immunology | 2 | 2.0 |
RNA, Messenger/biosynthesis/genetics | 2 | 0.0 |
